{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:33:11Z","timestamp":1776087191404,"version":"3.50.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1093\/eurheartj\/ehs122","type":"journal-article","created":{"date-parts":[[2012,5,30]],"date-time":"2012-05-30T00:49:58Z","timestamp":1338338998000},"page":"2297-2306","source":"Crossref","is-referenced-by-count":33,"title":["Reduced serum levels of vasostatin-2, an anti-inflammatory peptide derived from chromogranin A, are associated with the presence and severity of coronary artery disease"],"prefix":"10.1093","volume":"33","author":[{"given":"Lin","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li Jin","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen Quan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Er Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,5,29]]},"reference":[{"key":"key\n\t\t\t\t20170515131204_EHS122C1","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMra021405","article-title":"The chromogranin-secretogranin family","volume":"348","author":"Taupenot","year":"2003","journal-title":"N Engl J Med"},{"issue":"Pt. 18","key":"key\n\t\t\t\t20170515131204_EHS122C2","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1242\/jeb.027391","article-title":"Catecholamines, cardiac natriuretic peptides and chromogranin A: evolution and physiopathology of a \u2018whip-brake\u2019 system of the endocrine heart","volume":"213","author":"Tota","year":"2010","journal-title":"J Exp Biol"},{"key":"key\n\t\t\t\t20170515131204_EHS122C3","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1053\/euhj.2001.2977","article-title":"Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality","volume":"23","author":"Ceconi","year":"2002","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170515131204_EHS122C4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/eurheartj\/ehn513","article-title":"Prognostic value of circulating chromogranin A levels in acute coronary syndromes","volume":"30","author":"Jansson","year":"2009","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170515131204_EHS122C5","doi-asserted-by":"crossref","first-page":"927.e1","DOI":"10.1016\/j.ahj.2006.05.008","article-title":"Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction","volume":"152","author":"Estensen","year":"2006","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170515131204_EHS122C6","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1096\/fj.08-110239","article-title":"The homologous rat chromogranin A1\u201364 (rCGA1-64) modulates myocardial and coronary function in rat heart to counteract adrenergic stimulation indirectly via endothelium-derived nitric oxide","volume":"22","author":"Cerra","year":"2008","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t20170515131204_EHS122C7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.regpep.2006.04.007","article-title":"The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells","volume":"135","author":"Blois","year":"2006","journal-title":"Regul Pept"},{"key":"key\n\t\t\t\t20170515131204_EHS122C8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1096\/fj.03-0922fje","article-title":"Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage","volume":"18","author":"Ferrero","year":"2004","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t20170515131204_EHS122C9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.jid.5700484","article-title":"Novel anti-inflammatory properties of the angiogenesis inhibitor vasostatin","volume":"127","author":"Huegel","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"Suppl. 2","key":"key\n\t\t\t\t20170515131204_EHS122C10","doi-asserted-by":"crossref","first-page":"S314","DOI":"10.2337\/dc09-S330","article-title":"Endothelial dysfunction as a target for prevention of cardiovascular disease","volume":"32","author":"Versari","year":"2009","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20170515131204_EHS122C11","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","article-title":"Endothelial nitric oxide synthase in vascular disease: from marvel to menace","volume":"113","author":"Forstermann","year":"2006","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515131204_EHS122C12","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.2337\/db09-0538","article-title":"HDL as a biomarker, potential therapeutic target, and therapy","volume":"58","author":"Navab","year":"2009","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170515131204_EHS122C13","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515131204_EHS122C14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/cvr\/cvq076","article-title":"The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation","volume":"86","author":"Brasier","year":"2010","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20170515131204_EHS122C15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amjcard.2006.01.059","article-title":"Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease","volume":"98","author":"Ferrario","year":"2006","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170515131204_EHS122C16","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0735-1097(99)00126-6","article-title":"ACC\/AHA guidelines for coronary angiography. A report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions","volume":"33","author":"Scanlon","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl. 1","key":"key\n\t\t\t\t20170515131204_EHS122C17","first-page":"S13","article-title":"Standards of medical care in diabetes\u20142009","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20170515131204_EHS122C18","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170515131204_EHS122C19","first-page":"2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","volume-title":"JAMA","year":"2001"},{"key":"key\n\t\t\t\t20170515131204_EHS122C20","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0735-1097(01)01344-4","article-title":"ACC\/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)\u2014executive summary. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty)","volume":"37","author":"Smith","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170515131204_EHS122C21","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0002-9149(00)01163-2","article-title":"Angiographic severity and extent of coronary artery disease in patients with type 1 diabetes mellitus","volume":"86","author":"Pajunen","year":"2000","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170515131204_EHS122C22","first-page":"219","article-title":"The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease","volume":"1","author":"Sianos","year":"2005","journal-title":"EuroIntervention"},{"key":"key\n\t\t\t\t20170515131204_EHS122C23","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1161\/01.ATV.17.11.2646","article-title":"Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis","volume":"17","author":"De Caterina","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170515131204_EHS122C24","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.167.6.3099","article-title":"Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a\/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1","volume":"167","author":"Bechard","year":"2001","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170515131204_EHS122C25","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1096\/fj.09-134882","article-title":"Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells","volume":"23","author":"Elmasri","year":"2009","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t20170515131204_EHS122C26","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1161\/CIRCULATIONAHA.107.706986","article-title":"CC chemokine ligand-5 (CCL5\/RANTES) and CC chemokine ligand-18 (CCL18\/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms","volume":"116","author":"Kraaijeveld","year":"2007","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515131204_EHS122C27","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.108.814251","article-title":"C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men","volume":"118","author":"Ridker","year":"2008","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515131204_EHS122C28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20170515131204_EHS122C29","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1515\/CCLM.2010.340","article-title":"Statistical methods for assessment of added usefulness of new biomarkers","volume":"48","author":"Pencina","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"key\n\t\t\t\t20170515131204_EHS122C30","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1096\/fj.06-6829com","article-title":"The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial cell proliferation and migration","volume":"21","author":"Belloni","year":"2007","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t20170515131204_EHS122C31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jcb.22510","article-title":"Vasostatin 1 activates eNOS in endothelial cells through a proteoglycan-dependent mechanism","volume":"110","author":"Ramella","year":"2010","journal-title":"J Cell Biochem"},{"key":"key\n\t\t\t\t20170515131204_EHS122C32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbpa.2006.05.016","article-title":"New biological aspects of chromogranin A-derived peptides: focus on vasostatins","volume":"147","author":"Tota","year":"2007","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"key\n\t\t\t\t20170515131204_EHS122C33","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/01.ATV.0000183718.62409.ea","article-title":"C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant","volume":"25","author":"Singh","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170515131204_EHS122C34","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.thromres.2008.07.015","article-title":"Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes","volume":"123","author":"Sahli","year":"2009","journal-title":"Thromb Res"},{"key":"key\n\t\t\t\t20170515131204_EHS122C35","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1161\/01.CIR.103.15.1936","article-title":"Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis","volume":"103","author":"Newby","year":"2001","journal-title":"Circulation"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/33\/18\/2297\/17050387\/ehs122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T01:16:59Z","timestamp":1743211019000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1093\/eurheartj\/ehs122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,29]]},"references-count":35,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2012,5,29]]},"published-print":{"date-parts":[[2012,9]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehs122","relation":{},"ISSN":["1522-9645","0195-668X"],"issn-type":[{"value":"1522-9645","type":"electronic"},{"value":"0195-668X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5,29]]}}}